283
Views
7
CrossRef citations to date
0
Altmetric
Review

Thymosin beta 4 regulation of actin in sepsis

, , , &
Pages 193-197 | Received 12 Dec 2017, Accepted 01 Mar 2018, Published online: 06 Mar 2018

References

  • Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. Jama. 2017;318(13):1241–1249.
  • Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90–92.
  • Marshall J. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195–203.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
  • Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock; relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med. 2007;49(1):88–98.
  • Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011;107(1):57–64.
  • Chelazzi C, Villa G, Mancinelli P, et al. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care. 2015;19(1):26.
  • Loiacono L, Shapiro D. Detection of hypoxia at the cellular level. Crit Care Clin. 2010;26(2):409–422.
  • Rayment I, Holden H, Whittaker M, et al. Structure of the actin-myosin complex and its implications for muscle contraction. Science. 1993;261(5117):58–65.
  • Dominguez R, Holmes K. Actin structure and function. Annu Rev Biophys. 2011;40:169–186.
  • Meng W, Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harbor Perspect Biol. 2009;1(6):a002899.
  • Elzinga M, Collins J, Kuehl W, et al. Complete amino-acid sequence of actin of rabbit skeletal muscle. Proc Natl Acad Sci. 1973;70(9):2687–2691.
  • Xue B, Robinson R. Guardians of the actin monomer. Eur J Cell Biol. 2013;92:316–332.
  • Haddad J, Harper K, Guoth M, et al. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci U S A. 1990;87(4):1381–1385.
  • Belsky J, Morris DC, Bouchebl R, et al. Plasma levels of F-actin and F:G-actin ratio as potential new biomarkers in patients with septic shock. Biomarkers. 2016;21(2):180–185.
  • Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin β4 reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol. 2003;3(8):1225–1233.
  • Mannherz H, Hannappel E. The β-thymosins: intracellular and extracellular activities of a versatile actin binding protein family. Cell Motil Cytoskeleton. 2009;66(10):839–851.
  • Low T, Goldstein A. Chemical characterization of thymosin β4. J Biol Chem. 1982;257(2):1000–1006.
  • Badamchian M, Damavandy AA, Damavandy H, et al. Identification and quantification of thymosin β4 in human saliva and tears. Ann N Y Acad Sci. 2007;1112:458–465.
  • Bodendorf S, Born G, Hannappel E. Determination of thymosin β4 and protein in human wound fluid after abdominal surgery. Ann N Y Acad Sci. 2007;1112:418–424.
  • Qualtieri A, Urso E, Le Pera M, et al. Thymosin β4 is differentially expressed in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients: a MALDI-TOF MS protein profiling study. Prot Clin Appl. 2009;3:574–583.
  • Zoubek RE, Hannappel R. Subcellular distribution of thymosin beta4. Ann N Y Acad Sci. 2007;1112:442–450.
  • Sosne G, Qiu P, Goldstein A, et al. Biological activities of thymosin β4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144–2151.
  • Ruff D, Crockford D, Girardi G, et al. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin β4 in healthy volunteers. Ann N Y Acad Sci. 2010;1194:223–229.
  • Sosne G, Ousler GW. Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAETM) model. Clin Ophthalmol. 2015;20(9):877–884.
  • Sosne G, Dunn S, Kim C. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea. 2015;34(5):491–496.
  • Dunn SP, Heidemann DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin β4. Ann N Y Acad Sci. 2010;1194:199–206.
  • Sosne G, Chan CC, Thai K, et al. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res. 2001;72(5):605–608.
  • Sosne G, Qiu P, Christopherson PL, et al. Thymosin beta 4 suppression of corneal NF-κB: a potential anti-inflammatory pathway. Exp Eye Res. 2007;84(4):663–669.
  • Sosne G, Xu L, Prach L, et al. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res. 2004;293(1):175–183.
  • Sosne G, Siddiqi A, Kurpakus-Wheater M. Thymosin-beta 4 inhibits corneal epithelial cell apoptosis after ethanol exposure. Invest Ophthalmol Vis Sci. 2004;45(4):1095–1100.
  • Lee W, Galbraith R. The extracellular actin-scavenger system and actin toxicity. N Engl J Med. 1992;326:1335–1341.
  • Scarborough VD, Bradford HR, Ganguly P. Aggregation of platelets by muscle acting. A multivalent interaction model of platelet aggregation by ADP. Biochem Ciophys Res Commun. 1981;100(3):1314–1319.
  • Janmey PA, Lind SE, Yin HL, et al. Effects of semi-dilute actin solutions on the mobility of fibrin protofibrils during clot formation. Biochim Biophys Acta. 1985;841(2):151–158.
  • Laki K, Muszbek L. On the interaction of F-actin with fibrin. Biochim Biophys Acta. 1974;371(2):519–525.
  • Lind SE, Smith CJ. Actin accelerates plasmin generation by tissue plasminogen activator. J Biol Chem. 1991;266(26):17673–17678.
  • Lind SE, Smith CJ. Actin is a noncompetitive plasmin inhibitor. J Biol Chem. 1991;266(8):5273–5278.
  • Erukhimov JA, Tang ZL, Johnson BA, et al. Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am J Respir Crit Care Med. 2000;162(1):288–294.
  • Wei C, Kumar S, Kim I-K, et al. Thymosin Beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes. PLoS One. 2012;7(8):e42586.
  • Bongiovanni D, Ziegler T, D’Almeida S, et al. Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis. Expert Opin Biol Ther. 2015;15:S203–10.
  • Tzehoval E, Sztein MB, Goldstein AL. Thymosins alpha 1 and beta 4 potentiate the antigen-presenting capacity of macrophages. Immunopharmacology. 1989;18(2):107–113.
  • Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778(3):660–669.
  • Ince C, Mayeux PR, Nguyen T, et al. The endothelium in sepsis. Shock. 2016;45(3):259–270.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.